CJC-1295 with DAC is a long-acting analogue of growth hormone-releasing hormone (GHRH). The DAC modification extends its activity, making it a subject of research into growth hormone signalling and downstream IGF-1 responses.
Commonly researched areas of interest
Growth hormone-releasing hormone signalling
Pituitary growth hormone response
Insulin-like growth factor I pathways
Albumin binding and peptide persistence
Endocrine feedback mechanisms
Long-acting peptide pharmacology
Small controlled human studies have reported sustained growth hormone and IGF-I responses. These findings do not establish muscle-building, anti-ageing or general wellness benefits for this product.
For research use only. Not for human consumption.
CJC-1295 with DAC is a long-acting analogue of growth hormone-releasing hormone (GHRH). The DAC modification extends its activity, making it a subject of research into growth hormone signalling and downstream IGF-1 responses.
Commonly researched areas of interest
Growth hormone-releasing hormone signalling
Pituitary growth hormone response
Insulin-like growth factor I pathways
Albumin binding and peptide persistence
Endocrine feedback mechanisms
Long-acting peptide pharmacology
Small controlled human studies have reported sustained growth hormone and IGF-I responses. These findings do not establish muscle-building, anti-ageing or general wellness benefits for this product.
For research use only. Not for human consumption.
